Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. ” Source BBC: [link].

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 2 Goates et al. 4 [link].

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. MyMD Contact: Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients.

Policy 160

Policy Patients Education Legislation 160

Cannabis Law Report

JANUARY 4, 2022

With the conditional approval, ADCL can immediately employ the Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0 Hayward, president and CEO of Applied DNA, stated, “We are grateful to the NYSDOH for conditional approval of our Linea 2.0 Assay (the “Linea 2.0 The Linea 2.0 Dr. James A.

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

AUGUST 25, 2021

The purchase and amalgamation of Consolidated Craft Brands was announced on March 19, 2021 bringing CPG and pharmaceutical manufacturing experience and Health Canada licenses for R&D. Actual results and future events could differ materially from those anticipated in such forward-looking statements. www.rapid-dose.com.

Events 111

Events Pharmaceutical Research and Development Business 111

Cannabis Law Report

JUNE 16, 2021

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory.

Events 74

Events Access Legislation Conditions 74

Cannabis Law Report

AUGUST 25, 2021

The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. www.rapid-dose.com.

Research and Development 111

Research and Development Events Business Access 111

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines. Caution Regarding Forward-Looking Information.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Let’s find out. . Combat-Related PTSD is Slightly Different From PTSD .

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

NORML

FEBRUARY 1, 2019

And officials in San Francisco, California are considering a proposal to allow marijuana to be socially consumed and sold at temporary events. Click here to email your lawmakers in support of banking access. Click here to email your lawmakers in support of adding autism and opioid use to the list qualifying medical conditions.

Legislation 166

Legislation Decriminalization Access Patients 166

Cannabis Law Report

FEBRUARY 3, 2022

Nimbus Health is a privately owned, licensed pharmaceutical wholesaler from Germany focusing on medical cannabis in Germany. The closing of the transaction is subject to customary closing conditions. As more European countries adopt the usage of medical cannabis, the ability to leverage and access newer geographies will be key.

Pharmaceutical 52

Pharmaceutical Events Patients Medicine 52

Cannabis Law Report

DECEMBER 9, 2021

This novel technology will be welcomed in these markets as a truly innovative delivery mechanism, initially for nutraceuticals, with expansion into pharmaceuticals and vaccines to follow. Actual results and future events could differ materially from those anticipated in such forward-looking statements. www.rapid-dose.com.

Pharmaceutical 52

Pharmaceutical Research and Development Events Business 52

Cannabis Law Report

JUNE 1, 2021

The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and Licensed Processors (LPs) to monitor and manage formulation effects on patient and demographics. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

NOVEMBER 9, 2021

Experienced Cannabis Executive, Registered Pharmacist and European Patent Attorney to Lead Pharmaceutical Strategy & Operations, Corporate Quality Management, Legal & Regulatory Affairs. She will work closely with Akanda’s EU GMP processing and distribution partner Cantourage GmbH, based in Germany. Akkar-Schenkl. About Akanda Corp.

Pharmaceutical 52

Pharmaceutical Seed-To-Sale Supply Chain Events 52

Veriheal

SEPTEMBER 22, 2021

If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina. Home cannabis cultivation, on the other hand, would be forbidden.

Legalization 111

Legalization Patients Cultivation Legislation 111

The Joint Blog

JUNE 2, 2020

According to a new study published in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions. Adverse events were mostly mild and resolved spontaneously.

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Cannabis Law Report

JANUARY 5, 2022

The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. www.rapid-dose.com.

Research and Development 52

Research and Development Events Access Pharmaceutical 52

Cannabis Law Report

DECEMBER 22, 2021

The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. www.rapid-dose.com.

Research and Development 52

Research and Development Events Access Pharmaceutical 52

Cannabis Law Report

NOVEMBER 24, 2021

The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. www.rapid-dose.com.

Research and Development 52

Research and Development Events Access Pharmaceutical 52

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. How easy is it to access CBG products? What are you most interested in?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

NOVEMBER 9, 2021

Akanda launches with two key assets, CanMart and Bophelo, bringing pharmaceutical grade cannabis from Africa to supply UK, European and other international markets. We believe we have one of the industry’s best platforms to meet patient needs and gain market share in the rapidly growing international cannabis market.”.

Collective 52

Collective Supply Chain Seed-To-Sale Events 52

CannaTech

FEBRUARY 2, 2020

We were not participating in the official WEF events and did not carry the right colored badges to access all of the high profile locations. Instead, we hosted a fully dedicated cannabis lounge under the CannaTech umbrella, our premier cannabis events platform.

Medicine 59

Medicine Events Patients Access 59

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. As a result, many PD patients now have legal access to cannabis as an alternative or complementary therapy. After analyzing the data, the researchers found that 24.5%

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

OCTOBER 1, 2021

The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. www.rapid-dose.com.

Events 52

Events Access Pharmaceutical Cannabis 52

Cannabis Law Report

JANUARY 19, 2022

Psygen also provided Health Canada with consent to be identified on a public list as a licensed dealer able to provide GMP psilocybin for use in patients through Canada’s special access program (the “ SAP “). “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

SEPTEMBER 15, 2021

“We are very pleased with the successes realized to date with this important research endeavour including the ability to manufacture the spike protein infused QuickStrip at a high temperature and we are actively exploring pharmaceutical partnerships to continue to validate oral delivery of vaccines,” said Mark Upsdell, CEO, Rapid Dose Therapeutics.

Research and Development 52

Research and Development Pharmaceutical Events Access 52

Cannabis Law Report

JUNE 14, 2021

The closing of the transaction will be subject to customary closing conditions, including due diligence to the satisfaction of both parties and the entering into of definitive agreements. per share (the “Flora Share Price”). About Koch & Gsell. About Flora Growth Corp. Forward-looking statements are only predictions.

Hemp 106

Hemp Events Supply Chain Cultivation 106

Cannabis Law Report

SEPTEMBER 28, 2021

The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. www.rapiddose.ca.

Research and Development 52

Research and Development Events Business Access 52

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. Executive producer, Michael Schaeffer Omer-Man. Music by Desca. MSO: Wait, hold on.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

NOVEMBER 19, 2021

The initial public offering is expected to take place after the SEC completes its review process and is subject to market and other conditions. The number of shares to be offered and the price range for the proposed offering have not yet been determined. market with supply and distribution to pharmacies and clinics throughout the U.K.

Seed-To-Sale 52

Seed-To-Sale Events Cultivation Conditions 52

Cannabis Law Report

NOVEMBER 19, 2021

The initial public offering is expected to take place after the SEC completes its review process and is subject to market and other conditions. The number of shares to be offered and the price range for the proposed offering have not yet been determined. market with supply and distribution to pharmacies and clinics throughout the U.K.

Seed-To-Sale 52

Seed-To-Sale Events Cultivation Conditions 52